Andy W. Smith
Corporate Officer/Principal bei PharmaVentures Ltd.
Profil
Dr. Andy W.
Smith is a Portfolio Manager at AXA Investment Managers UK Ltd.
He joined AXA Framlington, the qualitative equity brand of AXA Investment Managers in April 2008 as Portfolio Manager within the healthcare team with specific responsibility for the AXA Framlington Biotech Fund.
Previously, he spent three years at SV Life Sciences where he was responsible for managing a global biotechnology investment fund.
From 2004 to 2005 he worked at Schroders as Director and Fund Manager, Global Equities.
Between 2002 and 2004 he worked within the Asset Management division of the 3i Group as Investment Manager and then Director.
From 1994 to 2000, he worked at SmithKline Beecham Pharmaceuticals & Consumer Healthcare as Project Manager, Dermatologicals (1994-1996), Assistant Director New Product Research (1996-1998) and Global Brand Manager, Bactroban & New Products (1998-2000).
From 1992 to 1994 Dr. Andy W.
Smith was a lecturer in Microbiology at UMDS Guy’s Hospital Medical School and from 1990 to 1992 Section Manager Microbiology Research at SmithKline Consumer Brands.
He started his career in 1985 as Senior Scientific Officer at ICI’s Plant Protection Division.
Dr. Andy W.
Smith has a PhD in Molecular Biology from the University of Nottingham (1990) and an MBA in International Marketing from the University of Greenwich (1996).
He graduated from North East London Polytechnic with a BSc (Hons.) in Applied Biology (Microbiology).
Aktive Positionen von Andy W. Smith
| Unternehmen | Position | Beginn |
|---|---|---|
PharmaVentures Ltd.
 PharmaVentures Ltd. Investment ManagersFinance Pharma Ventures Ltd. provides advisory services on life sciences transactions. It offers mergers and acquisitions, licensing, strategy and valuation, and expert services. The firm's industry coverage includes pharmaceuticals, biologics, drug delivery systems, diagnostics, medical devices, including telemedicine, medical software. The company is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 05.10.2011 |
Ehemalige bekannte Positionen von Andy W. Smith
| Unternehmen | Position | Ende |
|---|---|---|
AXA Investment Managers UK Ltd.
 AXA Investment Managers UK Ltd. Investment ManagersFinance AXA Investment Managers UK Ltd. (AXA IM-UK) is the UK-based investment subsidiary of AXA Framlington Group Ltd., itself a subsidiary of AXA SA (XP: CS, ADR: AXAHY) in France. The firm is headquartered in London and was founded in 1979. AXA IM-UK manages a diverse range of pooled funds and offers tailor-made investment products for liability management. They specialize in institutional pension fund management and individual retirement savings products. | Analyst-Equity | 01.06.2010 |
AXA Framlington Investment Management Ltd.
 AXA Framlington Investment Management Ltd. Investment Trusts/Mutual FundsMiscellaneous AXA Framlington Investment Management Ltd. (AFIM), is the UK investment management subsidiary of AXA Investment Managers SA, itself a subsidiary of AXA SA (XP: CS) in France. Established in 1972, the firm is based in London. AXA Framlington is the trading name of AXA Framlington Investment Management Ltd. In addition to the London office, they also have specialized fund managers in Paris. AFIM is committed to becoming a leader in Responsible Investment and supporting sustainable financial markets. Their clients include investment trusts, pension funds, charities, institutions, unit trusts and PEP and ISA investors. | Portfolio Manager-Aktien | 01.06.2009 |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Private Equity Investor | 29.02.2008 |
Schroder Investment Management Ltd.
 Schroder Investment Management Ltd. Investment ManagersFinance Schroder Investment Management Ltd. (SIM) is the wholly-owned asset management subsidiary of Schroder International Holdings Ltd., ultimately held by Great Britain-based Schroders Plc (LSE: SDR, ADR: SHNWY). Established in 1985, SIM is headquartered in London and caters to a range of clients such as corporations, insurance firms, local and public authorities, charities, pension funds, high net-worth individuals and retail investors. | Portfolio Manager-Aktien | 13.06.2005 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Schroder Investment Management Ltd.
Schroder Investment Management Ltd. Investment ManagersFinance Schroder Investment Management Ltd. (SIM) is the wholly-owned asset management subsidiary of Schroder International Holdings Ltd., ultimately held by Great Britain-based Schroders Plc (LSE: SDR, ADR: SHNWY). Established in 1985, SIM is headquartered in London and caters to a range of clients such as corporations, insurance firms, local and public authorities, charities, pension funds, high net-worth individuals and retail investors. | Finance |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Finance |
AXA Framlington Investment Management Ltd.
AXA Framlington Investment Management Ltd. Investment Trusts/Mutual FundsMiscellaneous AXA Framlington Investment Management Ltd. (AFIM), is the UK investment management subsidiary of AXA Investment Managers SA, itself a subsidiary of AXA SA (XP: CS) in France. Established in 1972, the firm is based in London. AXA Framlington is the trading name of AXA Framlington Investment Management Ltd. In addition to the London office, they also have specialized fund managers in Paris. AFIM is committed to becoming a leader in Responsible Investment and supporting sustainable financial markets. Their clients include investment trusts, pension funds, charities, institutions, unit trusts and PEP and ISA investors. | Miscellaneous |
AXA Investment Managers UK Ltd.
AXA Investment Managers UK Ltd. Investment ManagersFinance AXA Investment Managers UK Ltd. (AXA IM-UK) is the UK-based investment subsidiary of AXA Framlington Group Ltd., itself a subsidiary of AXA SA (XP: CS, ADR: AXAHY) in France. The firm is headquartered in London and was founded in 1979. AXA IM-UK manages a diverse range of pooled funds and offers tailor-made investment products for liability management. They specialize in institutional pension fund management and individual retirement savings products. | Finance |
PharmaVentures Ltd.
PharmaVentures Ltd. Investment ManagersFinance Pharma Ventures Ltd. provides advisory services on life sciences transactions. It offers mergers and acquisitions, licensing, strategy and valuation, and expert services. The firm's industry coverage includes pharmaceuticals, biologics, drug delivery systems, diagnostics, medical devices, including telemedicine, medical software. The company is headquartered in Oxford, the United Kingdom. | Finance |
